Delivery Order SPE2DB20D3303-SPE2DB24FZ0M5

Award Date 2/27/24
Potential Completion Date 2/28/24
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,629.58 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which was not set aside for any specific business type. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has a potential value of $6,518.32 and a completion date of January 26, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $31,405.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $21,184.54 contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside contract....
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $32,591.60, is for the provision of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $24,443.70 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The delivery order is for BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 8, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger, single-award indefinite delivery contract (IDC) valued...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,552.08 contract is for the supply of Beyfortus 100 mg/ml syringes, a pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as Amerisourcebergen's primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $24,443.70 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order contract is issued under...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $8,925.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical product BEYFORTUS 100 MG/ML SYRINGEML. This contract, which does not have a set-aside designation, is a task order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. Under this...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGE/ML pharmaceutical products. The $1,552.08 award has a performance period through February 28, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA that...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ0M5
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $1,552.08 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical and medical supply company, to provide BEYFORTUS 100 MG/ML SYRINGEML. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide critical healthcare materials to military treatment programs and facilities worldwide.

Generated 6/2/24, 1:01 AM